Literature DB >> 7822244

Specific assay method for the activities of cathepsin L-type cysteine proteinases.

T Inubushi1, H Kakegawa, Y Kishino, N Katunuma.   

Abstract

We have established a new differential assay method for cathepsin L-type proteinases using specific inhibitors, E-64 for all cysteine proteinases, CA-074 for cathepsin B, and PLCPI for cathepsin L-type proteinases with Z-Phe-Arg-MCA as the substrate. The value of cathepsin B calculated by this method did not coincide with value assayed directly in terms of the hydrolysis of Z-Arg-Arg-MCA, a specific substrate for cathepsin B. The activities of cathepsin L-type proteinases, cathepsins B and J in rat liver and kidney were assayed at the same time using this new assay method as a representative example.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7822244     DOI: 10.1093/oxfordjournals.jbchem.a124520

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus.

Authors:  E Bednarski; C E Ribak; G Lynch
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

2.  Potential Alzheimer's Disease Therapeutics Among Weak Cysteine Protease Inhibitors Exhibit Mechanistic Differences Regarding Extent of Cathepsin B Up-Regulation and Ability to Block Calpain.

Authors:  Heather Romine; Katherine M Rentschler; Kaitlan Smith; Ayanna Edwards; Camille Colvin; Karen Farizatto; Morgan C Pait; David Butler; Ben A Bahr
Journal:  Eur Sci J       Date:  2017-10

3.  Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells.

Authors:  Silvia Alvarez-Díaz; Noelia Valle; José Miguel García; Cristina Peña; José M P Freije; Víctor Quesada; Aurora Astudillo; Félix Bonilla; Carlos López-Otín; Alberto Muñoz
Journal:  J Clin Invest       Date:  2009-08       Impact factor: 14.808

4.  Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response.

Authors:  T Dainichi; Y Maekawa; K Ishii; T Zhang; B F Nashed; T Sakai; M Takashima; K Himeno
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

6.  Possible involvement of radical intermediates in the inhibition of cysteine proteases by allenyl esters and amides.

Authors:  Yoshio Takeuchi; Tomoya Fujiwara; Yoshihito Shimone; Hideki Miyataka; Toshio Satoh; Kenneth L Kirk; Hitoshi Hori
Journal:  Bioorg Med Chem Lett       Date:  2008-10-05       Impact factor: 2.823

7.  Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways.

Authors:  Karen L G Farizatto; Uzoma S Ikonne; Michael F Almeida; Merari F R Ferrari; Ben A Bahr
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

8.  An Active 32-kDa Cathepsin L Is Secreted Directly from HT 1080 Fibrosarcoma Cells and Not via Lysosomal Exocytosis.

Authors:  Yoko Hashimoto; Chihiro Kondo; Nobuhiko Katunuma
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

9.  Role of Endogenous Cathepsin L in Muscle Protein Degradation in Olive Flounder (Paralichthys olivaceus) Surimi Gel.

Authors:  Chang Woo Kwon; Pahn-Shick Chang
Journal:  Molecules       Date:  2021-03-28       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.